ID   NEK1_HUMAN              Reviewed;        1258 AA.
AC   Q96PY6; G5E9Z3; Q05DG5; Q14CB7; Q5H9T1; Q6PIB8; Q96SS2; Q9H6P7;
AC   Q9Y594;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-2002, sequence version 2.
DT   15-MAR-2017, entry version 160.
DE   RecName: Full=Serine/threonine-protein kinase Nek1;
DE            EC=2.7.11.1;
DE   AltName: Full=Never in mitosis A-related kinase 1;
DE            Short=NimA-related protein kinase 1;
DE   AltName: Full=Renal carcinoma antigen NY-REN-55;
GN   Name=NEK1; Synonyms=KIAA1901;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI.
RT   The complete sequences of 60 new cDNA clones from brain which code for
RT   large proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   GLY-724.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Bone marrow, and Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 91-1258 (ISOFORM 5), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 865-1258.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 444-1258 (ISOFORM 2), AND IDENTIFICATION
RP   AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-414; SER-418; SER-428;
RP   SER-653; SER-798; SER-834; SER-868 AND SER-881, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF VDAC1.
RX   PubMed=20230784; DOI=10.1016/j.bbrc.2010.03.077;
RA   Chen Y., Gaczynska M., Osmulski P., Polci R., Riley D.J.;
RT   "Phosphorylation by Nek1 regulates opening and closing of voltage
RT   dependent anion channel 1.";
RL   Biochem. Biophys. Res. Commun. 394:798-803(2010).
RN   [12]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INVOLVEMENT IN
RP   DIGENIC SHORT-RIB THORACIC DYSPLASIA 3/6 WITH POLYDACTYLY.
RX   PubMed=21211617; DOI=10.1016/j.ajhg.2010.12.004;
RA   Thiel C., Kessler K., Giessl A., Dimmler A., Shalev S.A.,
RA   von der Haar S., Zenker M., Zahnleiter D., Stoess H., Beinder E.,
RA   Abou Jamra R., Ekici A.B., Schroeder-Kress N., Aigner T., Kirchner T.,
RA   Reis A., Brandstaetter J.H., Rauch A.;
RT   "NEK1 mutations cause short-rib polydactyly syndrome type majewski.";
RL   Am. J. Hum. Genet. 88:106-114(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-156; SER-428; THR-661;
RP   SER-664; SER-868; SER-881 AND SER-1052, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1052, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH
RP   C21ORF2 AND SPATA7 BY MASS SPECTROMETRY, AND INTERACTION WITH C21ORF2.
RX   PubMed=26167768; DOI=10.1038/ncb3201;
RG   UK10K Consortium;
RG   University of Washington Center for Mendelian Genomics;
RA   Wheway G., Schmidts M., Mans D.A., Szymanska K., Nguyen T.M.,
RA   Racher H., Phelps I.G., Toedt G., Kennedy J., Wunderlich K.A.,
RA   Sorusch N., Abdelhamed Z.A., Natarajan S., Herridge W.,
RA   van Reeuwijk J., Horn N., Boldt K., Parry D.A., Letteboer S.J.,
RA   Roosing S., Adams M., Bell S.M., Bond J., Higgins J., Morrison E.E.,
RA   Tomlinson D.C., Slaats G.G., van Dam T.J., Huang L., Kessler K.,
RA   Giessl A., Logan C.V., Boyle E.A., Shendure J., Anazi S.,
RA   Aldahmesh M., Al Hazzaa S., Hegele R.A., Ober C., Frosk P.,
RA   Mhanni A.A., Chodirker B.N., Chudley A.E., Lamont R., Bernier F.P.,
RA   Beaulieu C.L., Gordon P., Pon R.T., Donahue C., Barkovich A.J.,
RA   Wolf L., Toomes C., Thiel C.T., Boycott K.M., McKibbin M.,
RA   Inglehearn C.F., Stewart F., Omran H., Huynen M.A., Sergouniotis P.I.,
RA   Alkuraya F.S., Parboosingh J.S., Innes A.M., Willoughby C.E.,
RA   Giles R.H., Webster A.R., Ueffing M., Blacque O., Gleeson J.G.,
RA   Wolfrum U., Beales P.L., Gibson T., Doherty D., Mitchison H.M.,
RA   Roepman R., Johnson C.A.;
RT   "An siRNA-based functional genomics screen for the identification of
RT   regulators of ciliogenesis and ciliopathy genes.";
RL   Nat. Cell Biol. 17:1074-1087(2015).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-10; LYS-25; VAL-76; PRO-294;
RP   GLY-355; VAL-463; THR-598; GLY-724; ASN-745; GLU-883 AND ASN-1180.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [18]
RP   VARIANTS SRTD6 ARG-145 AND SER-253.
RX   PubMed=22499340; DOI=10.1136/jmedgenet-2011-100717;
RA   El Hokayem J., Huber C., Couve A., Aziza J., Baujat G., Bouvier R.,
RA   Cavalcanti D.P., Collins F.A., Cordier M.P., Delezoide A.L.,
RA   Gonzales M., Johnson D., Le Merrer M., Levy-Mozziconacci A., Loget P.,
RA   Martin-Coignard D., Martinovic J., Mortier G.R., Perez M.J., Roume J.,
RA   Scarano G., Munnich A., Cormier-Daire V.;
RT   "NEK1 and DYNC2H1 are both involved in short rib polydactyly Majewski
RT   type but not in Beemer Langer cases.";
RL   J. Med. Genet. 49:227-233(2012).
CC   -!- FUNCTION: Phosphorylates serines and threonines, but also appears
CC       to possess tyrosine kinase activity. Implicated in the control of
CC       meiosis (By similarity). Involved in cilium assembly. In response
CC       to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to
CC       limit mitochondrial cell death. {ECO:0000250,
CC       ECO:0000269|PubMed:20230784, ECO:0000269|PubMed:21211617}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Binds to SPERT.Found in a complex with C21orf2, NEK1 and
CC       SPATA7 (PubMed:26167768). Interacts with NEK1 (PubMed:26167768).
CC       {ECO:0000250, ECO:0000269|PubMed:26167768}.
CC   -!- INTERACTION:
CC       Q99689:FEZ1; NbExp=2; IntAct=EBI-373615, EBI-396435;
CC       Q9UHY8:FEZ2; NbExp=2; IntAct=EBI-373615, EBI-396453;
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-373615, EBI-5323863;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:21211617}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000250}. Note=Associated with the pericentriolar material.
CC       Localizes to centrosome during interphase and mitosis (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q96PY6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96PY6-2; Sequence=VSP_004870;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96PY6-3; Sequence=VSP_035439;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q96PY6-4; Sequence=VSP_035435, VSP_035436;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q96PY6-5; Sequence=VSP_035437, VSP_035438;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q96PY6-6; Sequence=VSP_035436, VSP_035439;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High fetal expression in the brain and kidney.
CC       {ECO:0000269|PubMed:21211617}.
CC   -!- DISEASE: Short-rib thoracic dysplasia 6 with or without
CC       polydactyly (SRTD6) [MIM:263520]: A form of short-rib thoracic
CC       dysplasia, a group of autosomal recessive ciliopathies that are
CC       characterized by a constricted thoracic cage, short ribs,
CC       shortened tubular bones, and a 'trident' appearance of the
CC       acetabular roof. Polydactyly is variably present. Non-skeletal
CC       involvement can include cleft lip/palate as well as anomalies of
CC       major organs such as the brain, eye, heart, kidneys, liver,
CC       pancreas, intestines, and genitalia. Some forms of the disease are
CC       lethal in the neonatal period due to respiratory insufficiency
CC       secondary to a severely restricted thoracic cage, whereas others
CC       are compatible with life. Disease spectrum encompasses Ellis-van
CC       Creveld syndrome, asphyxiating thoracic dystrophy (Jeune
CC       syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly
CC       syndrome. {ECO:0000269|PubMed:22499340}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC       In some cases NEK1 mutations result in disease phenotype in the
CC       presence of mutations in DYNC2H1 indicating digenic inheritance
CC       (digenic short rib-polydactyly syndrome 3/6 with polydactyly)
CC       (PubMed:21211617). {ECO:0000269|PubMed:21211617}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH15147.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAB15207.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB55209.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB67794.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB067488; BAB67794.1; ALT_INIT; mRNA.
DR   EMBL; CR933642; CAI45943.1; -; mRNA.
DR   EMBL; AC116615; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC084724; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471056; EAX04791.1; -; Genomic_DNA.
DR   EMBL; BC015147; AAH15147.1; ALT_SEQ; mRNA.
DR   EMBL; BC037790; AAH37790.1; -; mRNA.
DR   EMBL; BC114491; AAI14492.1; -; mRNA.
DR   EMBL; AK025658; BAB15207.1; ALT_INIT; mRNA.
DR   EMBL; AK027580; BAB55209.1; ALT_INIT; mRNA.
DR   EMBL; AF155113; AAD42879.1; -; mRNA.
DR   CCDS; CCDS47162.1; -. [Q96PY6-1]
DR   CCDS; CCDS56348.1; -. [Q96PY6-4]
DR   CCDS; CCDS56349.1; -. [Q96PY6-2]
DR   CCDS; CCDS56350.1; -. [Q96PY6-6]
DR   CCDS; CCDS56351.1; -. [Q96PY6-3]
DR   RefSeq; NP_001186326.1; NM_001199397.1. [Q96PY6-3]
DR   RefSeq; NP_001186327.1; NM_001199398.1. [Q96PY6-6]
DR   RefSeq; NP_001186328.1; NM_001199399.1. [Q96PY6-4]
DR   RefSeq; NP_001186329.1; NM_001199400.1. [Q96PY6-2]
DR   RefSeq; NP_036356.1; NM_012224.2. [Q96PY6-1]
DR   RefSeq; XP_011530305.1; XM_011532003.1. [Q96PY6-1]
DR   RefSeq; XP_011530306.1; XM_011532004.1. [Q96PY6-2]
DR   UniGene; Hs.481181; -.
DR   PDB; 4APC; X-ray; 2.10 A; A/B=1-328.
DR   PDB; 4B9D; X-ray; 1.90 A; A/B=1-328.
DR   PDBsum; 4APC; -.
DR   PDBsum; 4B9D; -.
DR   ProteinModelPortal; Q96PY6; -.
DR   SMR; Q96PY6; -.
DR   BioGrid; 110825; 29.
DR   IntAct; Q96PY6; 25.
DR   STRING; 9606.ENSP00000424757; -.
DR   BindingDB; Q96PY6; -.
DR   ChEMBL; CHEMBL5855; -.
DR   GuidetoPHARMACOLOGY; 2114; -.
DR   iPTMnet; Q96PY6; -.
DR   PhosphoSitePlus; Q96PY6; -.
DR   BioMuta; NEK1; -.
DR   DMDM; 22256934; -.
DR   MaxQB; Q96PY6; -.
DR   PaxDb; Q96PY6; -.
DR   PeptideAtlas; Q96PY6; -.
DR   PRIDE; Q96PY6; -.
DR   TopDownProteomics; Q96PY6-3; -. [Q96PY6-3]
DR   Ensembl; ENST00000439128; ENSP00000408020; ENSG00000137601. [Q96PY6-1]
DR   Ensembl; ENST00000507142; ENSP00000424757; ENSG00000137601. [Q96PY6-3]
DR   Ensembl; ENST00000510533; ENSP00000427653; ENSG00000137601. [Q96PY6-2]
DR   Ensembl; ENST00000511633; ENSP00000423332; ENSG00000137601. [Q96PY6-6]
DR   Ensembl; ENST00000512193; ENSP00000424938; ENSG00000137601. [Q96PY6-4]
DR   GeneID; 4750; -.
DR   KEGG; hsa:4750; -.
DR   UCSC; uc003isb.3; human. [Q96PY6-1]
DR   CTD; 4750; -.
DR   DisGeNET; 4750; -.
DR   GeneCards; NEK1; -.
DR   HGNC; HGNC:7744; NEK1.
DR   HPA; HPA020873; -.
DR   HPA; HPA040413; -.
DR   MalaCards; NEK1; -.
DR   MIM; 263520; phenotype.
DR   MIM; 604588; gene.
DR   neXtProt; NX_Q96PY6; -.
DR   OpenTargets; ENSG00000137601; -.
DR   Orphanet; 93269; Short rib-polydactyly syndrome, Majewski type.
DR   PharmGKB; PA31545; -.
DR   eggNOG; KOG0589; Eukaryota.
DR   eggNOG; ENOG410Y7JF; LUCA.
DR   GeneTree; ENSGT00760000118997; -.
DR   HOVERGEN; HBG006460; -.
DR   InParanoid; Q96PY6; -.
DR   KO; K08857; -.
DR   OMA; KHKQAHQ; -.
DR   OrthoDB; EOG091G0GU4; -.
DR   PhylomeDB; Q96PY6; -.
DR   TreeFam; TF333575; -.
DR   SignaLink; Q96PY6; -.
DR   SIGNOR; Q96PY6; -.
DR   ChiTaRS; NEK1; human.
DR   GeneWiki; NEK1; -.
DR   GenomeRNAi; 4750; -.
DR   PRO; PR:Q96PY6; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000137601; -.
DR   CleanEx; HS_NEK1; -.
DR   ExpressionAtlas; Q96PY6; baseline and differential.
DR   Genevisible; Q96PY6; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0000242; C:pericentriolar material; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IMP:CACAO.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:CACAO.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Ciliopathy; Cilium biogenesis/degradation;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Kinase; Magnesium;
KW   Metal-binding; Mitosis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN         1   1258       Serine/threonine-protein kinase Nek1.
FT                                /FTId=PRO_0000086418.
FT   DOMAIN        4    258       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    128    128       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     156    156       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     162    162       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     414    414       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     418    418       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     428    428       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     438    438       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51954}.
FT   MOD_RES     653    653       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     661    661       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     664    664       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     798    798       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     834    834       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     868    868       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     881    881       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1052   1052       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1126   1126       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P51954}.
FT   VAR_SEQ     398    422       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035435.
FT   VAR_SEQ     477    520       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035436.
FT   VAR_SEQ     478    521       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10508479}.
FT                                /FTId=VSP_004870.
FT   VAR_SEQ     522    527       QKGQLA -> LDCDDP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035437.
FT   VAR_SEQ     528   1258       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035438.
FT   VAR_SEQ     555    555       M -> MGILQNLAAMYGGRPSSSRGGKPRNKEEE (in
FT                                isoform 3 and isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_035439.
FT   VARIANT      10     10       I -> F (in dbSNP:rs34214559).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040900.
FT   VARIANT      25     25       E -> K (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040901.
FT   VARIANT      76     76       L -> V (in dbSNP:rs35093214).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040902.
FT   VARIANT     145    145       G -> R (in SRTD6; dbSNP:rs431905508).
FT                                {ECO:0000269|PubMed:22499340}.
FT                                /FTId=VAR_069617.
FT   VARIANT     253    253       L -> S (in SRTD6).
FT                                {ECO:0000269|PubMed:22499340}.
FT                                /FTId=VAR_069618.
FT   VARIANT     294    294       A -> P (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040903.
FT   VARIANT     355    355       R -> G (in dbSNP:rs35763578).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040904.
FT   VARIANT     463    463       A -> V (in dbSNP:rs34540355).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040905.
FT   VARIANT     598    598       A -> T (in dbSNP:rs33933790).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046486.
FT   VARIANT     717    717       N -> K (in dbSNP:rs34324114).
FT                                /FTId=VAR_061743.
FT   VARIANT     724    724       E -> G (in dbSNP:rs34099167).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_051651.
FT   VARIANT     745    745       K -> N. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040906.
FT   VARIANT     883    883       Q -> E (in dbSNP:rs6828134).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046488.
FT   VARIANT    1180   1180       D -> N (in dbSNP:rs35503975).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046489.
FT   CONFLICT    250    250       N -> D (in Ref. 2; CAI45943).
FT                                {ECO:0000305}.
FT   CONFLICT    602    602       R -> RK (in Ref. 2; CAI45943).
FT                                {ECO:0000305}.
FT   CONFLICT   1232   1232       G -> E (in Ref. 7; AAD42879).
FT                                {ECO:0000305}.
FT   STRAND        4      9       {ECO:0000244|PDB:4B9D}.
FT   STRAND       18     23       {ECO:0000244|PDB:4B9D}.
FT   TURN         24     26       {ECO:0000244|PDB:4B9D}.
FT   STRAND       29     36       {ECO:0000244|PDB:4B9D}.
FT   HELIX        42     57       {ECO:0000244|PDB:4B9D}.
FT   STRAND       66     72       {ECO:0000244|PDB:4B9D}.
FT   STRAND       75     81       {ECO:0000244|PDB:4B9D}.
FT   HELIX        88     94       {ECO:0000244|PDB:4B9D}.
FT   TURN         95     97       {ECO:0000244|PDB:4B9D}.
FT   HELIX       102    121       {ECO:0000244|PDB:4B9D}.
FT   HELIX       131    133       {ECO:0000244|PDB:4B9D}.
FT   STRAND      134    136       {ECO:0000244|PDB:4B9D}.
FT   STRAND      142    144       {ECO:0000244|PDB:4B9D}.
FT   STRAND      149    151       {ECO:0000244|PDB:4B9D}.
FT   HELIX       155    164       {ECO:0000244|PDB:4B9D}.
FT   HELIX       172    175       {ECO:0000244|PDB:4B9D}.
FT   HELIX       182    198       {ECO:0000244|PDB:4B9D}.
FT   HELIX       208    217       {ECO:0000244|PDB:4B9D}.
FT   HELIX       229    238       {ECO:0000244|PDB:4B9D}.
FT   HELIX       243    245       {ECO:0000244|PDB:4B9D}.
FT   HELIX       249    253       {ECO:0000244|PDB:4B9D}.
FT   HELIX       256    259       {ECO:0000244|PDB:4B9D}.
FT   HELIX       260    264       {ECO:0000244|PDB:4B9D}.
FT   HELIX       268    275       {ECO:0000244|PDB:4B9D}.
SQ   SEQUENCE   1258 AA;  142828 MW;  339C4BFA56612530 CRC64;
     MEKYVRLQKI GEGSFGKAIL VKSTEDGRQY VIKEINISRM SSKEREESRR EVAVLANMKH
     PNIVQYRESF EENGSLYIVM DYCEGGDLFK RINAQKGVLF QEDQILDWFV QICLALKHVH
     DRKILHRDIK SQNIFLTKDG TVQLGDFGIA RVLNSTVELA RTCIGTPYYL SPEICENKPY
     NNKSDIWALG CVLYELCTLK HAFEAGSMKN LVLKIISGSF PPVSLHYSYD LRSLVSQLFK
     RNPRDRPSVN SILEKGFIAK RIEKFLSPQL IAEEFCLKTF SKFGSQPIPA KRPASGQNSI
     SVMPAQKITK PAAKYGIPLA YKKYGDKKLH EKKPLQKHKQ AHQTPEKRVN TGEERRKISE
     EAARKRRLEF IEKEKKQKDQ IISLMKAEQM KRQEKERLER INRAREQGWR NVLSAGGSGE
     VKAPFLGSGG TIAPSSFSSR GQYEHYHAIF DQMQQQRAED NEAKWKREIY GRGLPERGIL
     PGVRPGFPYG AAGHHHFPDA DDIRKTLKRL KAVSKQANAN RQKGQLAVER AKQVEEFLQR
     KREAMQNKAR AEGHMVYLAR LRQIRLQNFN ERQQIKAKLR GEKKEANHSE GQEGSEEADM
     RRKKIESLKA HANARAAVLK EQLERKRKEA YEREKKVWEE HLVAKGVKSS DVSPPLGQHE
     TGGSPSKQQM RSVISVTSAL KEVGVDSSLT DTRETSEEMQ KTNNAISSKR EILRRLNENL
     KAQEDEKGKQ NLSDTFEINV HEDAKEHEKE KSVSSDRKKW EAGGQLVIPL DELTLDTSFS
     TTERHTVGEV IKLGPNGSPR RAWGKSPTDS VLKILGEAEL QLQTELLENT TIRSEISPEG
     EKYKPLITGE KKVQCISHEI NPSAIVDSPV ETKSPEFSEA SPQMSLKLEG NLEEPDDLET
     EILQEPSGTN KDESLPCTIT DVWISEEKET KETQSADRIT IQENEVSEDG VSSTVDQLSD
     IHIEPGTNDS QHSKCDVDKS VQPEPFFHKV VHSEHLNLVP QVQSVQCSPE ESFAFRSHSH
     LPPKNKNKNS LLIGLSTGLF DANNPKMLRT CSLPDLSKLF RTLMDVPTVG DVRQDNLEID
     EIEDENIKEG PSDSEDIVFE ETDTDLQELQ ASMEQLLREQ PGEEYSEEEE SVLKNSDVEP
     TANGTDVADE DDNPSSESAL NEEWHSDNSD GEIASECECD SVFNHLEELR LHLEQEMGFE
     KFFEVYEKIK AIHEDEDENI EICSKIVQNI LGNEHQHLYA KILHLVMADG AYQEDNDE
//
